Literature DB >> 26400105

Towards aspirin-inspired self-immolating molecules which target the cyclooxygenases.

Christopher R Drake1, Luis Estévez-Salmerón, Philippe Gascard, Yang Shen, Thea D Tlsty, Ella F Jones.   

Abstract

Cyclooxygenases (COXs) are enzymes that play a vital role in the inflammatory cascade through the generation of prostaglandins. Their over-expression has been implicated in numerous diseases. In particular, over-expression of COX-2 has been shown to be a predictive biomarker for progression of pre-malignant lesions towards invasive cancer in various tissues. This makes the early detection of COX-2 expressing lesions of high clinical relevance. Herein we describe the development of the first self-immolating trigger which targets COXs. We incorporated our trigger design into 2 activatable fluorogenic probes and demonstrated COX-specific activation in vitro. Experimental data revealed probe activation was likely caused by solvent-exposed amino acids on the surface of the COXs. Overall, the probes reported here mark the first step towards developing self-immolating imaging/therapeutic agents targeted to specific COXs.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26400105      PMCID: PMC4644089          DOI: 10.1039/c5ob01805f

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  23 in total

Review 1.  Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.

Authors:  Daniel L Simmons; Regina M Botting; Timothy Hla
Journal:  Pharmacol Rev       Date:  2004-09       Impact factor: 25.468

2.  Selective esterase-ester pair for targeting small molecules with cellular specificity.

Authors:  Lin Tian; Yunlei Yang; Laura M Wysocki; Alma C Arnold; Amy Hu; Balaji Ravichandran; Scott M Sternson; Loren L Looger; Luke D Lavis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

3.  Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents.

Authors:  Md Jashim Uddin; Brenda C Crews; Anna L Blobaum; Philip J Kingsley; D Lee Gorden; J Oliver McIntyre; Lynn M Matrisian; Kotha Subbaramaiah; Andrew J Dannenberg; David W Piston; Lawrence J Marnett
Journal:  Cancer Res       Date:  2010-05-01       Impact factor: 12.701

Review 4.  Mechanism of free radical oxygenation of polyunsaturated fatty acids by cyclooxygenases.

Authors:  Carol A Rouzer; Lawrence J Marnett
Journal:  Chem Rev       Date:  2003-06       Impact factor: 60.622

Review 5.  Development of fluorescent probes based on protection-deprotection of the key functional groups for biological imaging.

Authors:  Yonghe Tang; Dayoung Lee; Jiaoliang Wang; Guanhan Li; Jinghua Yu; Weiying Lin; Juyoung Yoon
Journal:  Chem Soc Rev       Date:  2015-05-14       Impact factor: 54.564

6.  Aspirin-like molecules that covalently inactivate cyclooxygenase-2.

Authors:  A S Kalgutkar; B C Crews; S W Rowlinson; C Garner; K Seibert; L J Marnett
Journal:  Science       Date:  1998-05-22       Impact factor: 47.728

7.  6-aminoquinoline as a fluorogenic leaving group in peptide cleavage reactions: a new fluorogenic substrate for chymotrypsin.

Authors:  P J Brynes; P Bevilacqua; A Green
Journal:  Anal Biochem       Date:  1981-09-15       Impact factor: 3.365

Review 8.  Cyclooxygenase 2: a molecular target for cancer prevention and treatment.

Authors:  Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Trends Pharmacol Sci       Date:  2003-02       Impact factor: 14.819

Review 9.  The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment.

Authors:  Alexander Greenhough; Helena J M Smartt; Amy E Moore; Heather R Roberts; Ann C Williams; Christos Paraskeva; Abderrahmane Kaidi
Journal:  Carcinogenesis       Date:  2009-01-09       Impact factor: 4.944

10.  Activatable Optical Probes for the Detection of Enzymes.

Authors:  Christopher R Drake; David C Miller; Ella F Jones
Journal:  Curr Org Synth       Date:  2011-08       Impact factor: 1.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.